Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zefeng Xu

Showing results (51-60 of 121) with videos related to

Pageof 13
Sort By:
Nanomaterials (Basel, Switzerland)|February 26, 2022
SnSe-Coated Microfiber Resonator for All-Optical ModulationLei Chen, Jingyuan Ming, Zhishen Zhang, et al.
Leukemia & Lymphoma|August 13, 2013
+ 252A/G polymorphism in lymphotoxin-α gene influences long-term survival in patients with myelodysplastic syndrome with excess blastsJunqing Xu, Jieyu Wang, Xiaofei Ai, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 4, 2015
[Long- term outcome of thalidomide and cyclosporine in patients with IPSS low/intermediate- 1 myelodysplastic syndromes]Jingya Wang, Tiejun Qin, Zefeng Xu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 10, 2015
[Prognostic evaluation of comorbidities in patients with myelodysplastic syndrome]Yi Li, Tiejun Qin, Zefeng Xu, et al.
Hematology (Amsterdam, Netherlands)|October 13, 2025
The prognostic impact of chromosome 7 with both arms loss [der(7)del(7p)del(7q)] in myelodysplastic syndrome/neoplasmJi Zhou, Linlin Liu, Chenghua Cui, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 26, 2014
[Comparison of low-dose thalidomide and prednisone combined with or without danazol for the treatment of primary myelofibrosis-associated anemia]Junqing Xu, Zefeng Xu, Tiejun Qin, et al.
British Journal of Haematology|December 28, 2019
Mutational features of myelodysplastic syndromes with Auer rods reveal them are more akin to acute myeloid leukemiaHuijun Huang, Tiejun Qin, Zefeng Xu, et al.
Leukemia & Lymphoma|January 7, 2021
<i>STAT3</i> and <i>STAT5B</i> mutations have unique distribution in T-cell large granular lymphocyte proliferations and advanced myeloid neoplasmsShiqiang Qu, Yujiao Jia, Huijun Wang, et al.
Leukemia Research|October 27, 2012
TET2, ASXL1 and EZH2 mutations in Chinese with myelodysplastic syndromesJieyu Wang, Xiaofei Ai, Robert Peter Gale, et al.
American Journal of Hematology|April 10, 2016
The different prognostic impact of type-1 or type-1 like and type-2 or type-2 like CALR mutations in patients with primary myelofibrosisBing Li, Zefeng Xu, Yan Li, et al.
Pageof 13

Showing results (51-60 of 121) with videos related to

Sort By:
Pageof 13
Nanomaterials (Basel, Switzerland)|February 26, 2022
SnSe-Coated Microfiber Resonator for All-Optical ModulationLei Chen, Jingyuan Ming, Zhishen Zhang, et al.
Leukemia & Lymphoma|August 13, 2013
+ 252A/G polymorphism in lymphotoxin-α gene influences long-term survival in patients with myelodysplastic syndrome with excess blastsJunqing Xu, Jieyu Wang, Xiaofei Ai, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 4, 2015
[Long- term outcome of thalidomide and cyclosporine in patients with IPSS low/intermediate- 1 myelodysplastic syndromes]Jingya Wang, Tiejun Qin, Zefeng Xu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 10, 2015
[Prognostic evaluation of comorbidities in patients with myelodysplastic syndrome]Yi Li, Tiejun Qin, Zefeng Xu, et al.
Hematology (Amsterdam, Netherlands)|October 13, 2025
The prognostic impact of chromosome 7 with both arms loss [der(7)del(7p)del(7q)] in myelodysplastic syndrome/neoplasmJi Zhou, Linlin Liu, Chenghua Cui, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 26, 2014
[Comparison of low-dose thalidomide and prednisone combined with or without danazol for the treatment of primary myelofibrosis-associated anemia]Junqing Xu, Zefeng Xu, Tiejun Qin, et al.
British Journal of Haematology|December 28, 2019
Mutational features of myelodysplastic syndromes with Auer rods reveal them are more akin to acute myeloid leukemiaHuijun Huang, Tiejun Qin, Zefeng Xu, et al.
Leukemia & Lymphoma|January 7, 2021
<i>STAT3</i> and <i>STAT5B</i> mutations have unique distribution in T-cell large granular lymphocyte proliferations and advanced myeloid neoplasmsShiqiang Qu, Yujiao Jia, Huijun Wang, et al.
Leukemia Research|October 27, 2012
TET2, ASXL1 and EZH2 mutations in Chinese with myelodysplastic syndromesJieyu Wang, Xiaofei Ai, Robert Peter Gale, et al.
American Journal of Hematology|April 10, 2016
The different prognostic impact of type-1 or type-1 like and type-2 or type-2 like CALR mutations in patients with primary myelofibrosisBing Li, Zefeng Xu, Yan Li, et al.
Pageof 13